Latest Nephrology news and features
Latest Urology news and features
Download our free app for iOS or Android
August 2011
PRAGUE—Taking antihypertensive medications at bedtime significantly reduces cardiovascular disease (CVD) risk compared with ingesting the drugs upon awakening, according to researchers.
BALTIMORE—Primary androgen deprivation therapy (PADT) does not prolong survival as much as radical prostatectomy (RP) among men with localized prostate cancer (PCa), a new retrospective ...
SAN DIEGO—Linagliptin, a dipeptidyl peptidase (DPP)-4 inhibitor, appears to be a good treatment option for patients with type 2 diabetes and severe renal impairment, researchers ...
Traditional nephrology training makes us believe that it is good practice to start maintenance dialysis therapy sooner rather than later. Nevertheless, recent data indicate that ...
Elevated levels of fibroblast growth factor 23 (FGF-23) is an independent risk factor for end-stage renal disease (ESRD) in patients with relatively preserved kidney function ...
Early data show promising results for cabozantinib, a new therapeutic agent for castration-resistant prostate cancer (CRPC), particularly against tumors that have metastasized to the bone.
The FDA is calling for more conservative dosing of erythropoiesis-stimulating agents (ESAs) when used to treat anemia in CKD patients due to the increased risks ...
In a study of 436 patients with chronic kidney disease not on dialysis (mean age 65.1 years), ambulatory blood pressure (BP) measurements showed risk of ...
Nocturnal hemodialysis significantly improves the ability of early-outgrowth endothelial progenitor-like cells (EPLCs) to promote the growth of new blood vessels and thus restore perfusion in ...
A study comparing 325 men with palpable varicoceles and 510 men with vasectomy reversal without varicoceles revealed that men with varicocele had significantly lower testosterone ...
Etiology and treatment are clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome.
Dr. Z's office was crowded, but this was nothing new. The 61-year old urologist had built a thriving practice, primarily from referrals from his network ...
Malpractice awards may be at an all time low in the United States, according to the consumer watchdog group, Public Citizen.
Nurse practitioners and physician assistants (PA) are increasingly being used in hospital emergency departments.
In a highly unusual twist to a medical malpractice lawsuit, a juror was arrested in the middle of a trial and accused with soliciting bribes ...
Clinical trials show that bardoxolone methyl not only maintains renal function, but improves it.
After the earthquake and tsunami struck Japan, markets sank throughout Asia. Investors worried that the devastation would disrupt power producers and hurt a wide range ...
WASHINGTON, D.C.—Silodosin may be an effective treatment for moderate or severe chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), researchers reported at the American Urological Association 2011 ...
MONTREAL—Patients with locally advanced prostate cancer (PCa) have significantly better long-term biochemical disease-free survival (bDFS) if they are treated with external beam radiation therapy (EBRT) ...
MONTREAL—The timing of radiation therapy (RT) after radical prostatectomy (RP) for prostate cancer does not affect the rate of urinary incontinence, bladder neck contracture, and ...
PRAGUE—Therapy with bardoxolone, an oral antioxidant inflammation modulator, is associated with improved kidney function out to one year in patients with advanced chronic kidney disease ...
MONTREAL—Denosumab significantly prolongs bone metastasis-free survival (BMFS) and delays time to bone metastasis in men with castration-resistant prostate cancer (CRPC), according to data presented at ...
PRAGUE—Renal transplant recipients who have anemia three months after receiving a kidney are more likely to have anemia more than six months post-transplant, according to ...
PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting ...
CHICAGO—Prostate cancer (PCa) patients on androgen deprivation therapy (ADT) and receiving sipuleucel-T (Provenge) have no adverse outcomes in terms of quality of life (QoL), according ...
CHICAGO—An investigational drug called axitinib is more effective than sorafenib in prolonging progression-free survival (PFS) in patients previously treated for metastatic renal cell carcinoma (mRCC), ...
WASHINGTON, D.C.—The FDA has approved the first and only testosterone therapy applied to the underarm.
VANCOUVER, B.C.—A German team is gathering information to create a tool to accurately predict which dialysis patients are most likely to succumb to sudden cardiac ...
NEW ORLEANS—The combination of sustained-release naltrexone and bupropion leads to sustained clinically meaningful weight loss and improves markers of cardiovascular risk in obese patients, according ...
